ONYX-015 engineered adenovirus: Phase I Update

The 30-patient head and neck studies evaluated doses from 10superscript7-10superscript11 plaque-forming units (pfu), and

Read the full 143 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE